Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Apr 16, 2021
Open Peer Review Period: Apr 16, 2021 - Jun 11, 2021
Date Accepted: Nov 21, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Patients’ Perspectives on Transforming Clinical Trial Participation: Large Online Vignette-based Survey

Nguyen VT, Ravaud P, Tran VT, Young B, Boutron I

Patients’ Perspectives on Transforming Clinical Trial Participation: Large Online Vignette-based Survey

J Med Internet Res 2022;24(2):e29691

DOI: 10.2196/29691

PMID: 35103603

PMCID: 8848233

Patients’ preferences on randomised trials’ visit organization (on site or remotely) and impact on potential participation: A large online vignette-based survey Abstract

  • Van Thu Nguyen; 
  • Philippe Ravaud; 
  • Viet Thi Tran; 
  • Bridget Young; 
  • Isabelle Boutron

ABSTRACT

Background:

Information about patients’ preferences of the way a trial is organised could inform the trial planning to enhance participation rate.

Objective:

To describe patients’ preferences on the organisation of a randomised controlled trial (RCT) (visits on site or remotely) and evaluate the potential impact of fulfilling preferences on their willingness to participate in a clinical trial.

Methods:

Study design: Vignette-based survey. Vignette development: Vignettes were case scenarios of real clinical trials assessing pharmacological treatments. These RCTs evaluated six prevalent chronic diseases (i.e., osteoporosis, osteoarthritis, asthma, cardiovascular diseases, diabetes and endometriosis). Each vignette described: 1) the RCT and characteristics of treatment tested (i.e., doses, administration route), 2) the trial procedures and different options (son site or remotely) for how the trial was organised for i) informed consent; ii) follow-up visits; iii) communication of results when the trial is completed. Participants: We recruited participants from ComPare (www.compare.aphp.fr), a French e-cohort of patients with chronic diseases. Outcomes: Outcomes were participants’ preferences for the way trial was organised (on site or remotely) and their willingness to participate in the trial.

Results:

628 participants (78% female, median age 55) with different chronic diseases ranging from 59 patients with endometriosis to 133 patients with asthma answered the vignettes. Only 6% wanted to have informed consent and all trial visits on site, 28% wished to participate in a trial entirely remotely, 66% wanted to combine remote-based and hospital-based visits. Considering the trial as a whole, when the trial was organised in a way that patients preferred, the median (Q1-Q3) likelihood of participation in the trial was 90% (80-100) versus 60% (30-80) if the trial followed patients’ non-preferred model.

Conclusions:

There is an important diversity in participants’ preferences. Most participants preferred hybrid organisation involving both onsite and remote visits. Participants were more likely to participate in a trial organized according to their preferences.


 Citation

Please cite as:

Nguyen VT, Ravaud P, Tran VT, Young B, Boutron I

Patients’ Perspectives on Transforming Clinical Trial Participation: Large Online Vignette-based Survey

J Med Internet Res 2022;24(2):e29691

DOI: 10.2196/29691

PMID: 35103603

PMCID: 8848233

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.